Peptide Health Digest Logo
Clinical TrialsCognitive & Neuro Health(Tuftsin Analog)

Selank

A synthetic heptapeptide derived from human tuftsin, researched for anxiolytic, nootropic, and immunomodulatory properties without sedation.

Known Aliases:TP-7
Selank 3D Molecular Conformation Artwork
Biological DomainCognitive & Neuro Health
Molecular Conformation Visualization
Bioactive Specifications27 Amino Acids
Half-Life

~15 - 20 minutes (rapid neural uptake)

Receptor Target

GABA-A Receptors

Molecular Formula

C33H57N11O9

Administration

Administered via intranasal spray for direct olfactory-to-brain uptake.

Rigorous Scientific Hierarchy

Evidence Quality Snapshot

Independent Literature Synthesis
Human Evidence
Moderate

Small or observational human data; warrants clinical caution.

Preclinical Evidence
Extensive

Animal (rodent) and in-vitro cellular assays. Does NOT prove human efficacy.

Clinical / Regulatory
Clinical Trials

Formal regulatory oversight and verified clinical development phase.

Evidence classification for Selank: Human clinical data is strictly differentiated from non-human animal and in-vitro laboratory assays.

Pharmacokinetics & Chemical Specification

Biological Half-Life~15 - 20 minutes (rapid neural uptake)
Molecular Mass751.87 g/mol
CAS Registration129954-34-3
Primary Target Receptors:
GABA-A ReceptorsBDNF PathwayEnkephalinase Degradation Inhibition
Chemical Formula:

C33H57N11O9

Amino Acid Sequence:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

What is Selank?

Developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank combines the immunogenic tuftsin fragment with a Pro-Gly-Pro tripeptide to enhance metabolic stability. Research highlights anxiolytic activity comparable to benzodiazepines but without addictive potential, sedation, or cognitive impairment.

Biological Mechanism

Modulates GABAergic neurotransmission, influences monoamine neurotransmitter metabolism (serotonin and dopamine turnover), and upregulates brain-derived neurotrophic factor (BDNF) mRNA in the hippocampus.

Scientific Studies & Clinical Evidence

Peer-reviewed publications, clinical trials, and preclinical research investigating Selank.

No studies linked directly to this compound yet. Check back for upcoming additions.

Educational Dosing References

Documented literature dosing intervals and published clinical trial protocols.

Clinical dosing parameters are determined in trial contexts. Review the linked studies above for specific protocol arms.

Need to convert milligrams to syringe units?

Use our interactive mathematical tool for vial concentration and volume conversions.

Administration Methods & Handling

Biological delivery routes and standardized laboratory reconstitution principles.

Administration Summary

Administered via intranasal spray for direct olfactory-to-brain uptake.

Reconstitution & Storage Standard

Lyophilized peptides must be reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) and maintained strictly refrigerated between 2°C - 8°C (36°F - 46°F), shielded from light.

View Full Preparation Protocol

Related Research News

Recent articles referencing Selank.

No news articles currently published for this compound.

Where This Information Came From: Scientific Sources

Compiled from peer-reviewed biomedical literature, public clinical trial registries, and recognized reference catalog databases.

Transparent Attribution
Primary Scientific & Clinical Registries

Pharmacological profiles, receptor targets, and clinical data are verified against primary registries:

Secondary & Reference Catalog Resources

Community research topics, peptide nomenclature, and aliases are cross-referenced with public catalogs:

This topic was identified through research of publicly available peptide resources and peer-reviewed literature. Peptide Health Digest provides independent scientific explanations and does not endorse commercial distribution.